N-[5-(3-amino-1,1,1-trifluoro-2-hydroxypropan-2-yl)-7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[5-[5-(4-cyclopropyloxy-3-methoxyphenyl)-2-hydroxy-5-oxopentan-2-yl]-7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-5-(2,2,2-trifluoroacetyl)-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-5-(1,1,1-trifluoro-2-hydroxy-3-nitropropan-2-yl)-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide
C123H123F13N10O17S4 — CID 158510884
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-(3-amino-1,1,1-trifluoro-2-hydroxypropan-2-yl)-7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[5-[5-(4-cyclopropyloxy-3-methoxyphenyl)-2-hydroxy-5-oxopentan-2-yl]-7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-5-(2,2,2-trifluoroacetyl)-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-5-(1,1,1-trifluoro-2-hydroxy-3-nitropropan-2-yl)-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide
N-[5-(3-amino-1,1,1-trifluoro-2-hydroxypropan-2-yl)-7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[5-[5-(4-cyclopropyloxy-3-methoxyphenyl)-2-hydroxy-5-oxopentan-2-yl]-7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-5-(2,2,2-trifluoroacetyl)-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-5-(1,1,1-trifluoro-2-hydroxy-3-nitropropan-2-yl)-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide (PubChem CID 158510884) has the molecular formula C123H123F13N10O17S4 and a molecular weight of 2388.63 g/mol. Its IUPAC name is N-[5-(3-amino-1,1,1-trifluoro-2-hydroxypropan-2-yl)-7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[5-[5-(4-cyclopropyloxy-3-methoxyphenyl)-2-hydroxy-5-oxopentan-2-yl]-7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-5-(2,2,2-trifluoroacetyl)-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-5-(1,1,1-trifluoro-2-hydroxy-3-nitropropan-2-yl)-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide.
Molecular Properties
| Compound Name | N-[5-(3-amino-1,1,1-trifluoro-2-hydroxypropan-2-yl)-7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[5-[5-(4-cyclopropyloxy-3-methoxyphenyl)-2-hydroxy-5-oxopentan-2-yl]-7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-5-(2,2,2-trifluoroacetyl)-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-5-(1,1,1-trifluoro-2-hydroxy-3-nitropropan-2-yl)-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide |
|---|---|
| PubChem CID | 158510884 |
| Molecular Formula | C123H123F13N10O17S4 |
| Molecular Weight | 2388.63 g/mol |
| Exact Mass | 2386.77 |
| IUPAC Name | N-[5-(3-amino-1,1,1-trifluoro-2-hydroxypropan-2-yl)-7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[5-[5-(4-cyclopropyloxy-3-methoxyphenyl)-2-hydroxy-5-oxopentan-2-yl]-7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-5-(2,2,2-trifluoroacetyl)-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide;N-[7-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]-5-(1,1,1-trifluoro-2-hydroxy-3-nitropropan-2-yl)-2H-furo[2,3-c]pyridin-3-yl]-2-methylpropane-2-sulfinamide |
| SMILES | CC(C)(C)S(=O)NC1(/C=C/c2ccccc2)COc2c1cc(C(=O)C(F)(F)F)nc2-c1ccc(F)cc1.CC(C)(C)S(=O)NC1(/C=C/c2ccccc2)COc2c1cc(C(O)(CN)C(F)(F)F)nc2-c1ccc(F)cc1.CC(C)(C)S(=O)NC1(/C=C/c2ccccc2)COc2c1cc(C(O)(C[N+](=O)[O-])C(F)(F)F)nc2-c1ccc(F)cc1.COc1cc(C(=O)CCC(C)(O)c2cc3c(c(-c4ccc(F)cc4)n2)OCC3(/C=C/c2ccccc2)NS(=O)C(C)(C)C)ccc1OC1CC1 |
| InChI | InChI=1S/C40H43FN2O6S.C28H27F4N3O5S.C28H29F4N3O3S.C27H24F4N2O3S/c1-38(2,3)50(46)43-40(22-19-26-9-7-6-8-10-26)25-48-37-31(40)24-35(42-36(37)27-11-14-29(41)15-12-27)39(4,45)21-20-32(44)28-13-18-33(34(23-28)47-5)49-30-16-17-30;1-25(2,3)41(39)34-26(14-13-18-7-5-4-6-8-18)17-40-24-21(26)15-22(27(36,16-35(37)38)28(30,31)32)33-23(24)19-9-11-20(29)12-10-19;1-25(2,3)39(37)35-26(14-13-18-7-5-4-6-8-18)17-38-24-21(26)15-22(27(36,16-33)28(30,31)32)34-23(24)19-9-11-20(29)12-10-19;1-25(2,3)37(35)33-26(14-13-17-7-5-4-6-8-17)16-36-23-20(26)15-21(24(34)27(29,30)31)32-22(23)18-9-11-19(28)12-10-18/h6-15,18-19,22-24,30,43,45H,16-17,20-21,25H2,1-5H3;4-15,34,36H,16-17H2,1-3H3;4-15,35-36H,16-17,33H2,1-3H3;4-15,33H,16H2,1-3H3/b22-19+;3*14-13+ |
| InChIKey | HLAOVXXKXVSQEM-SUXLTGTISA-N |
| XLogP | 23.86 |
| TPSA | 387.33 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 167 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2388.63 |
| LogP ≤ 5 | 23.86 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 22 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158510884 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.